<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="brief-report" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Trop Med Hyg</journal-id><journal-id journal-id-type="iso-abbrev">Am J Trop Med Hyg</journal-id><journal-id journal-id-type="pmc-domain-id">960</journal-id><journal-id journal-id-type="pmc-domain">tropmed</journal-id><journal-id journal-id-type="publisher-id">tpmd</journal-id><journal-title-group><journal-title>The American Journal of Tropical Medicine and Hygiene</journal-title></journal-title-group><issn pub-type="ppub">0002-9637</issn><issn pub-type="epub">1476-1645</issn><publisher><publisher-name>The American Society of Tropical Medicine and Hygiene</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11229630</article-id><article-id pub-id-type="pmcid-ver">PMC11229630.1</article-id><article-id pub-id-type="pmcaid">11229630</article-id><article-id pub-id-type="pmcaiid">11229630</article-id><article-id pub-id-type="pmid">38806043</article-id><article-id pub-id-type="doi">10.4269/ajtmh.23-0863</article-id><article-id pub-id-type="publisher-id">tpmd230863</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>Clinical Characteristics and Outcomes of Disseminated Strongyloidiasis in the United States&#8212;A Multicenter Network Analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Henao-Mart&#237;nez</surname><given-names initials="AF">Andr&#233;s F.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Olivo Freites</surname><given-names initials="C">Christian</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Agudelo Higuita</surname><given-names initials="NI">Nelson I.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marcos</surname><given-names initials="LA">Luis A.</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chastain</surname><given-names initials="DB">Daniel B.</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mohareb</surname><given-names initials="AM">Amir M.</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tuells</surname><given-names initials="J">Jose</given-names></name><xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Villalpando-Carrion</surname><given-names initials="S">Salvador</given-names></name><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Franco-Paredes</surname><given-names initials="C">Carlos</given-names></name><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref><xref rid="aff12" ref-type="aff">
<sup>12</sup>
</xref><xref rid="aff13" ref-type="aff">
<sup>13</sup>
</xref></contrib><aff id="aff1"><label><sup>1</sup></label>Division of Infectious Diseases, Department of Medicine, University of Colorado Denver, Aurora, Colorado;</aff><aff id="aff2"><label><sup>2</sup></label>Ryan Health, Infectious Diseases, New York, New York;</aff><aff id="aff3"><label><sup>3</sup></label>University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma;</aff><aff id="aff4"><label><sup>4</sup></label>Instituto de Enfermedades Infecciosas y de Parasitolog&#237;a Antonio Vidal, Tegucigalpa, Honduras;</aff><aff id="aff5"><label><sup>5</sup></label>Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Stony Brook University, Stony Brook, New York;</aff><aff id="aff6"><label><sup>6</sup></label>Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, Georgia;</aff><aff id="aff7"><label><sup>7</sup></label>Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts;</aff><aff id="aff8"><label><sup>8</sup></label>Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts;</aff><aff id="aff9"><label><sup>9</sup></label>Department of Medicine, Harvard Medical School, Boston, Massachusetts;</aff><aff id="aff10"><label><sup>10</sup></label>Department of Community Nursing, Preventive Medicine and Public Health and History of Science, University of Alicante, Alicante, Spain;</aff><aff id="aff11"><label><sup>11</sup></label>Hospital Infantil de M&#233;xico, Ciudad de M&#233;xico, M&#233;xico;</aff><aff id="aff12"><label><sup>12</sup></label>Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City, Republic of Panama;</aff><aff id="aff13"><label><sup>13</sup></label>Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado</aff></contrib-group><author-notes><fn fn-type="present-address"><p>Authors&#8217; addresses: Andr&#233;s F. Henao-Mart&#237;nez, Division of Infectious Diseases, Department of Medicine, University of Colorado Denver, Aurora, CO, E-mail: <email>andres.henaomartinez@cuanschutz.edu</email>. Christian Olivo Freites, Ryan Health, Infectious Diseases, New York, NY, E-mail: <email>christianolivo.freites@ryanhealth.org</email>. Nelson I. Agudelo Higuita, University of Oklahoma Health Sciences Center, Oklahoma City, OK, and Instituto de Enfermedades Infecciosas y de Parasitolog&#237;a Antonio Vidal, Tegucigalpa, Honduras, E-mail: <email>nelson-agudelo-higuita@ouhsc.edu</email>. Luis A. Marcos, Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Stony Brook University, Stony Brook, NY, E-mail: <email>luis.marcosraymundo@stonybrookmedicine.edu</email>. Daniel B. Chastain, Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, E-mail: <email>daniel.chastain@uga.edu</email>. Amir M. Mohareb, Center for Global Health, Massachusetts General Hospital, Boston, MA, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, and Department of Medicine, Harvard Medical School. Boston, MA, E-mail: <email>amohareb@mgh.harvard.edu</email>. Jose Tuells, Department of Community Nursing, Preventive Medicine and Public Health and History of Science, University of Alicante, Alicante, Spain, E-mail: <email>tuells@ua.es</email>. Salvador Villalpando-Carrion, Hospital Infantil de M&#233;xico, Ciudad de M&#233;xico, M&#233;xico, E-mail: <email>villalpandoca@himfg.edu.mx</email>. Carlos Franco-Paredes, Hospital Infantil de M&#233;xico, Ciudad de M&#233;xico, M&#233;xico, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City, Republic of Panama, and Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO., E-mail: <email>carlos.franco.paredes@gmail.com</email>.</p></fn><corresp id="cor1"><label>*</label>Address correspondence to Andr&#233;s F. Henao-Mart&#237;nez, University of Colorado Anschutz Medical Campus, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO 80045. E-mail: <email>andres.henaomartinez@cuanschutz.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2024</year></pub-date><volume>111</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">466300</issue-id><fpage>89</fpage><lpage>92</lpage><history><date date-type="received"><day>05</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-01 00:25:17.390"><day>01</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024, American Society of Tropical Medicine and Hygiene</copyright-statement><copyright-year>2024</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ajtmh.23-0863.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="ajtmh.23-0863.pdf"/><abstract><title>ABSTRACT.</title><p>Human strongyloidiasis is a potentially life-threatening parasitic disease among immunocompromised hosts. We aim to determine the factors and mortality associated with disseminated strongyloidiasis. We conducted a U.S.-based multicenter retrospective cohort study to determine 90-day clinical outcomes for people diagnosed with <italic toggle="yes">Strongyloides</italic> infection in the TriNetX patient database. We identified adult patients with the <italic toggle="yes">International Classification of Diseases</italic> (10th revision, clinical modification) code for <italic toggle="yes">Strongyloides</italic> infection (B78) or a positive <italic toggle="yes">Strongyloides</italic> IgG antibody test and captured outcomes at 90 days. We identified 5,434 patients with strongyloidiasis, of whom 48 had disseminated strongyloidiasis for 0.9% prevalence of disseminated disease. Systemic connective tissue disorders, pulmonary eosinophilia, liver cirrhosis, blood disorders (monoclonal gammopathy, aplastic anemia, and lymphoid malignancy), malnutrition, alcohol use disorder, and transplantation status were frequent in patients with disseminated disease. Mortality was significantly higher in people with disseminated disease at 30 days (21%). The 90-day risk of hospitalization, bacteremia, and acute respiratory distress syndrome (ARDS) was higher in those with disseminated infection. People with disseminated strongyloidiasis had a heightened risk of hospitalization, bacteremia, acute respiratory distress syndrome, and mortality. The population at risk for severe strongyloidiasis infection is evolving, reflecting conditions in which glucocorticoids or additional immunosuppressive medications are commonly used for treatment.</p></abstract><counts><page-count count="4"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="disclaimer"><p>
<named-content content-type="print-only">Note: Supplemental materials appear at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ajtmh.org" ext-link-type="uri">www.ajtmh.org</ext-link>.</named-content>
</p></notes></front></article></pmc-articleset>